Search

Legend Biotech Corp ADR

Gesloten

SectorGezondheidszorg

17.57 0.11

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

17.18

Max

17.84

Belangrijke statistieken

By Trading Economics

Inkomsten

88M

33M

Verkoop

82M

388M

EPS

0.09

Winstmarge

8.568

Werknemers

3,200

EBITDA

92M

60M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+160.84% upside

Dividenden

By Acuity

Volgende Winsten

11 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-393M

3.6B

Vorige openingsprijs

17.46

Vorige sluitingsprijs

17.57

Nieuwssentiment

By Acuity

100%

0%

321 / 339 Rangschikking in Healthcare

Legend Biotech Corp ADR Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 sep 2026, 23:46 UTC

Legend Biotech Corp saw a modest increase in after-market trading, though it remains significantly below its 20-day moving average.

16 sep 2026, 20:10 UTC

News

Legend Biotech Corp shares fell sharply today despite reporting second-quarter CARVYKTI sales of $657 million, marking the tenth consecutive session of declines.

15 sep 2026, 22:02 UTC

Legend Biotech shares were roughly flat in after-market hours, remaining significantly below their 20-day moving average after nine consecutive lower sessions.

14 sep 2026, 19:36 UTC

Shares of Legend Biotech Corp are lower today, continuing a broader trend. The stock remains significantly below its 20-day moving average.

11 sep 2026, 23:26 UTC

Legend Biotech Corp shares are higher in after-market trading, reflecting notable gains since Friday's close amid speculation about Federal Reserve interest rate hikes.

9 sep 2026, 20:07 UTC

Legend Biotech Corp shares are lower, continuing a trend of four consecutive daily declines. The stock remains below its 20-day moving average.

8 sep 2026, 23:06 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, recovering from a recent decline that saw three consecutive lower closes.

3 sep 2026, 19:47 UTC

Shares of Legend Biotech Corp are lower today, despite earlier fluctuations that reached a session high. The stock remains above its 20-day moving average.

2 sep 2026, 20:03 UTC

News

Legend Biotech shares are higher as management discusses CARVYKTI's commercial rollout and plans to expand manufacturing capabilities at the Morgan Stanley Global Healthcare Conference.

1 sep 2026, 20:01 UTC

News

Legend Biotech will participate in the Morgan Stanley Global Healthcare Conference on September 15, 2026, as shares trade higher since Monday's close.

31 aug 2026, 22:16 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting a shift from recent higher daily closes amid broader market reactions to inflation comments from the Fed.

28 aug 2026, 20:07 UTC

Legend Biotech Corp shares are lower today, marking a fourth consecutive decline. Rising U.S. Treasury yields may be impacting investor sentiment.

27 aug 2026, 22:26 UTC

Legend Biotech Corp. shares are higher in after-market trading, gaining slightly since Thursday's close amid routine market fluctuations.

26 aug 2026, 23:11 UTC

Legend Biotech Corp shares are higher in after-market hours, reflecting the broader market's upward trend amid positive sentiment from major stocks.

25 aug 2026, 19:06 UTC

Shares of Legend Biotech Corp are higher today, remaining above their 20-day moving average amid positive market sentiment linked to falling oil prices.

24 aug 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, continuing a strong upward trend since Monday's close. The stock remains above its 20-day moving average.

21 aug 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, maintaining a position near the upper end of their one-month trading range.

20 aug 2026, 23:46 UTC

Legend Biotech Corp. shares are trading higher in after-market hours, diverging from broader market pressures amid rising crude oil prices and geopolitical tensions.

19 aug 2026, 23:01 UTC

Legend Biotech Corp shares are higher in after-market trading, showing notable strength and exceeding the 20-day moving average. No specific news was identified.

18 aug 2026, 20:03 UTC

Social Media

Legend Biotech Corp shares are higher today, buoyed by strong investor sentiment and analyst confidence in significant upside potential for the stock.

14 aug 2026, 19:36 UTC

Shares of Legend Biotech Corp are trading higher, though fluctuations have been routine during the session. The stock remains below its 20-day moving average.

13 aug 2026, 23:21 UTC

Legend Biotech Corp shares are higher in after-market hours, gaining traction following notable trading activity after Thursday's close. No specific news was identified.

12 aug 2026, 23:16 UTC

Legend Biotech Corp. shares are higher in after-market hours, reflecting positive market conditions amid a Consumer Price Index report that met forecasts.

11 aug 2026, 23:46 UTC

Shares of Legend Biotech Corp are higher in after-market hours, maintaining a position above the 20-day moving average amid stable trading conditions.

10 aug 2026, 23:06 UTC

Shares of Legend Biotech are higher in after-market trading, settling above Monday's close despite mixed market sentiment and geopolitical tensions.

7 aug 2026, 23:46 UTC

Shares of Legend Biotech Corp traded higher in after-market hours, amid a broader market context of a declining unemployment rate.

6 aug 2026, 20:06 UTC

Legend Biotech Corp shares are higher today, reflecting a shift from recent trends. No specific company news was identified to explain this movement.

4 aug 2026, 19:36 UTC

Legend Biotech Corp shares are higher today, recovering from an earlier low. Positive momentum persists despite a decline in U.S. core factory orders.

3 aug 2026, 22:01 UTC

Shares of Legend Biotech Corp are higher in after-market trading, reflecting gains since Monday's close amid broader market advances in tech and oil-sensitive sectors.

31 jul 2026, 23:56 UTC

Shares of Legend Biotech Corp. are higher in after-market trading, despite a slight decline earlier in the session and broader market weakness.

Peer Vergelijking

Prijswijziging

Legend Biotech Corp ADR Prognose

Koersdoel

By TipRanks

160.84% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 45.856 USD  160.84%

Hoogste 74 USD

Laagste 24 USD

Gebaseerd op 9 Wall Street-analisten die 12-maands prijsdoelen bieden voor Legend Biotech Corp ADR - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

9 ratings

5

Buy

4

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Legend Biotech Corp ADR

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.